Keyphrases
Co-treatment
9%
Dose Effect
9%
Fibrosis
9%
Glucose Consumption
18%
Healing
9%
Inflammatory Mediators
9%
Inhibition Rate
9%
Interleukin-1 Receptor Antagonist (IL-1Ra)
9%
Interleukin-1β
100%
Lactate
18%
Mediated Action
9%
Nitrite
9%
Nitrite Accumulation
9%
Organ System
9%
Ovulation
9%
Ovulatory
9%
Polypeptide
9%
Potent Inhibitor
100%
Prostaglandin E2
18%
Receptor 1
9%
Steady State
9%
Transforming Growth Factor-β
100%
Type I interleukin-1 Receptor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Fibrinogen
100%
Fibrosis
10%
Interleukin 1
100%
Interleukin 1 Receptor Blocking Agent
10%
Interleukin 1 Receptor Type I
10%
Lactic Acid
20%
Nitrite
20%
Polypeptide
10%
Prostaglandin E2
20%
Transforming Growth Factor
100%
Immunology and Microbiology
Interleukin 1
100%
Interleukin 1 Receptor Antagonist
10%
Interleukin 1 Receptor, Type I
10%
Interleukin-1
10%
Mediator
10%
Organ Systems
10%
Ovary
10%
Ovulation
10%
Promoter Region
10%
Prostaglandin E2
20%
Steady State
10%
Transforming Growth Factor
100%
Agricultural and Biological Sciences
Endpoints
9%
Interleukin 1 Receptor Antagonist
9%
Interleukin 1 Receptor, Type I
9%
Interleukin-1
100%
Nitrite
18%
Ovulation
9%
Polypeptide
9%
Prostaglandin E2
18%
Transforming Growth Factor
100%
Biochemistry, Genetics and Molecular Biology
Interleukin 1 Receptor Antagonist
9%
Interleukin 1 Receptor, Type I
9%
Interleukin-1
100%
Mediator
9%
Ovulation
9%
Promoter Region
9%
Prostaglandin E2
18%
Steady State
9%
Transforming Growth Factor
100%